LCL161 increases paclitaxel-induced apoptosis by degrading cIAP1 and cIAP2 in NSCLC. | |
Yang Chengcheng; Wang Huangzhen; Zhang Boxiang; Chen Yimeng; Zhang Yamin; Sun Xin; Xiao Guodong; Nan Kejun; Ren Hong; Qin Sida | |
刊名 | Journal of experimental & clinical cancer research : CR |
2016 | |
卷号 | 35页码:158 |
关键词 | Apoptosis NSCLC cIAP Paclitaxel LCL161 |
ISSN号 | 1756-9966 |
URL标识 | 查看原文 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/2954897 |
专题 | 西安交通大学 |
推荐引用方式 GB/T 7714 | Yang Chengcheng,Wang Huangzhen,Zhang Boxiang,et al. LCL161 increases paclitaxel-induced apoptosis by degrading cIAP1 and cIAP2 in NSCLC.[J]. Journal of experimental & clinical cancer research : CR,2016,35:158. |
APA | Yang Chengcheng.,Wang Huangzhen.,Zhang Boxiang.,Chen Yimeng.,Zhang Yamin.,...&Qin Sida.(2016).LCL161 increases paclitaxel-induced apoptosis by degrading cIAP1 and cIAP2 in NSCLC..Journal of experimental & clinical cancer research : CR,35,158. |
MLA | Yang Chengcheng,et al."LCL161 increases paclitaxel-induced apoptosis by degrading cIAP1 and cIAP2 in NSCLC.".Journal of experimental & clinical cancer research : CR 35(2016):158. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论